Mylan n.v. (MYL)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Cash flows from operating activities:
Net earnings (loss)

16

352

696

480

847

933

626

643

Adjustments to reconcile net (loss) earnings to net cash provided by (used in) operating activities:
Depreciation and amortization

2,019

2,109

1,805

1,523

1,032

566

516

546

Share-based Compensation

56

-3

74

88

92

66

47

42

Change in estimated sales allowances

-

-

-

-

-

-

345

265

Deferred income tax (benefit) expense

-192

-264

-111

-609

-115

-315

-87

-108

Unrealized losses on acquisition-related foreign currency derivatives

-

-

-

-128

0

0

-

-

Loss from equity method investments

-62

-78

-58

-112

-105

-91

-34

-16

Write off of financing fees

0

2

3

35

99

0

0

-

Other non-cash items

-360

-286

-261

-499

-263

-139

-127

-219

Litigation settlements and other contingencies, net

11

31

40

-597

-15

-7

14

3

Changes in operating assets and liabilities:
Accounts receivable

20

-340

162

131

-65

231

553

354

Inventories

512

547

129

279

320

147

157

172

Accounts payable

-96

220

14

87

131

-0

137

81

Income taxes

57

-23

15

37

-164

78

-1

-50

Deferred revenue

-

-

-

-

-

-

-

-19

Other operating assets and liabilities, net

-63

177

420

523

44

173

-85

157

Net cash provided by (used in) operating activities

1,803

2,341

2,064

2,047

2,008

1,014

1,106

949

Cash flows from investing activities:
Cash paid for acquisitions, net

148

65

167

6,481

693

50

1,261

0

Capital expenditures

213

252

275

390

362

325

334

305

Other Payments to Acquire Businesses

-

-

-

308

0

0

-

-

Settlement of acquisition-related foreign currency derivatives

-

-

-

128

0

0

-

-

Proceeds from sale of assets and subsidiaries

28

29

86

0

0

-

-

-

Change in restricted cash

-

-

-

-

-21

5

228

-7

Proceeds from sale of property, plant and equipment

-

-

-

-

-

-

25

16

Purchase of available for sale securities and other investments

25

63

96

30

62

19

19

9

Proceeds from the sale of marketable securities

27

85

96

21

33

20

10

8

Payments for product rights and other, net

192

943

620

360

506

420

60

80

Net cash used in investing activities

-525

-1,210

-976

-7,677

-1,569

-800

-1,868

-364

Cash flows from financing activities:
Proceeds from issuance of long-term debt

7

2,577

876

11,752

3,539

2,235

4,974

2,043

Payments of long-term debt

1,108

3,165

2,232

6,296

4,484

2,295

3,480

1,990

Proceeds from convertible note hedge

-

-

-

-

1,970

0

0

-

Change in short-term borrowings, net

-1

-44

-2

40

-329

-107

141

174

Taxes paid related to net share settlement of equity awards

8

10

7

17

31

27

0

0

Contingent consideration payments

60

11

26

35

0

150

0

0

Payments of financing fees

3

21

10

112

130

5

34

7

Payments for Repurchase of Common Stock

0

432

500

0

67

0

1,000

999

Proceeds from exercise of stock options

8

17

17

13

97

53

76

143

Acquisition of noncontrolling interest

0

0

7

1

11

0

0

-

Other items, net

-2

-1

-0

0

51

30

15

25

Net cash used in financing activities

-1,169

-1,090

-1,893

5,344

604

-267

692

-611

Effect on cash of changes in exchange rates

-7

-21

27

-9

-33

-12

10

1

Net increase (decrease) in cash, cash equivalents and restricted cash

101

19

-777

-295

1,010

-65

-58

-25

Supplemental disclosures of cash flow information —
Non-cash transactions:
Contingent consideration

-

-

4

16

18

-

-

-

Ordinary shares issued for acquisition

-

-

-

1,281

6,305

0

0

-

Cash paid during the period for:
Income taxes

278

228

285

285

302

210

189

308

Interest

470

460

474

357

254

273

249

246

Retained Earnings [Member]
Net earnings

16

352

696

480

-

-

-

-

Other current liabilities
Contingent consideration

0

0

4

16

-

-

-

-